Stockreport

Aquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024 [Seeking Alpha]

Aquestive Therapeutics, Inc.  (AQST) 
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aquestive.com/investor-relations
PDF The company is moving forward with plans to file a New Drug Application (NDA) and has several upcoming catalysts, including self-administration and allergen studies. [Read more]